Skip to content

Clinical trials

Phase 1 Inflammatory Bowel Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Phase 1 Country / region: United States Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20094
20102
20123
20132
20143
20154
20161
20172
20184
20192
20203
20213
20227
20232
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Terminated6
Recruiting3
Withdrawn3
Not yet recruiting2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Theravance Biopharma4
Pfizer3
Stanford University3
Brigham and Women's Hospital2
Bristol-Myers Squibb2
Direct Biologics, LLC2
National Institute of Allergy and Infectious Diseases (NIAID)2
University of California, San Francisco2
Altheus Therapeutics, Inc.1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases44
Colitis, Ulcerative23
Crohn Disease15
Arthritis, Psoriatic3
Lupus Erythematosus, Systemic3
Psoriasis3
Cholangitis, Sclerosing2
Clostridium Infections2
Colorectal Neoplasms2
Inflammation2

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.